Biotech firm with obesity ambitions: We aim for an agreement within a few years
The Danish-founded biotech company Pila Pharma looks to secure a partnership or acquisition within the next few years. The short-term goal is to advance the development of a promising new drug candidate for the treatment of obesity and diabetes.
